Arch Virol
- DAHER-NASHIF S, Al-Anany R, Ali M, Erradi K, et al
COVID-19 exit strategy during vaccine implementation: a balance between social
distancing and herd immunity.
Arch Virol. 2022 Jun 20. pii: 10.1007/s00705-022-05495.
Biochem Biophys Res Commun
- LYKHMUS O, Kalashnyk O, Koval L, Krynina O, et al
Immunization with 674-685 fragment of SARS-Cov-2 spike protein induces
neuroinflammation and impairs episodic memory of mice.
Biochem Biophys Res Commun. 2022;622:57-63.
BMJ
- BADELL ML, Dude CM, Rasmussen SA, Jamieson DJ, et al
Covid-19 vaccination in pregnancy.
BMJ. 2022;378:e069741.
- BOSCOLO-RIZZO P, Polesel J, Vaira LA
Smell and taste dysfunction after covid-19.
BMJ. 2022;378:o1653.
- MAHASE E
Covid-19: What we know about the BA.4 and BA.5 omicron variants.
BMJ. 2022;378:o1969.
- ELLIS SJ
Covid-19 impact on patients: ease of access should be a clear aim of the NHS.
BMJ. 2022;378:o1941.
- MAHASE E
Covid-19: One in eight adults develops long covid symptoms, study suggests.
BMJ. 2022;378:o1946.
Cell
- LI L, Liao H, Meng Y, Li W, et al
Structural basis of human ACE2 higher binding affinity to currently circulating
Omicron SARS-CoV-2 sub-variants BA.2 and BA.1.1.
Cell. 2022;185:2952-2960.
- DOLTON G, Rius C, Hasan MS, Wall A, et al
Emergence of immune escape at dominant SARS-CoV-2 killer T cell epitope.
Cell. 2022;185:2936-2951.
Drug Saf
- KANT A, van Hunsel F
Authors' Reply to Mungmunpuntipantip et al.'s Comment on "Description of
Frequencies of Reported Adverse Events Following Immunization Among Four
Different COVID-19 Vaccine Brands".
Drug Saf. 2022;45:925-926.
- MUNGMUNPUNTIPANTIP R, Wiwanitkit V
Comment on "Description of Frequencies of Reported Adverse Events Following
Immunization Among Four Different COVID-19 Vaccine Brands".
Drug Saf. 2022;45:923.
J Epidemiol Community Health
- ZELNER J, Naraharisetti R
Declining COVID-19 mortality risk ratios must be interpreted with caution.
J Epidemiol Community Health. 2022;76:840.
J Exp Med
- HALE M, Netland J, Chen Y, Thouvenel CD, et al
IgM antibodies derived from memory B cells are potent cross-variant neutralizers
of SARS-CoV-2.
J Exp Med. 2022;219.
J Immunol
- DAI M, Sun H, Zhao L, Wu Q, et al
Duck CD8(+) T Cell Response to H5N1 Highly Pathogenic Avian Influenza Virus
Infection In Vivo and In Vitro.
J Immunol. 2022 Aug 8. pii: jimmunol.2101147. doi: 10.4049/jimmunol.2101147.
J Infect Dis
- MAO Z, Li X, Korsten K, Bont L, et al
Economic Burden and Health-Related Quality of Life of Respiratory Syncytial Virus
and Influenza Infection in European Community-Dwelling Older Adults.
J Infect Dis. 2022;226.
J Virol
- GUO H, Li A, Lin HF, Liu MQ, et al
The Glycan-Binding Trait of the Sarbecovirus Spike N-Terminal Domain Reveals an
Evolutionary Footprint.
J Virol. 2022 Jul 19:e0095822. doi: 10.1128/jvi.00958.
- PUSNIK J, Konig J, Mai K, Richter E, et al
Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2
Infection and Vaccination Recall Response.
J Virol. 2022 Jul 12:e0076022. doi: 10.1128/jvi.00760.
- FARRUKEE R, Gunalan V, Maurer-Stroh S, Reading PC, et al
Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses
Bearing the H275Y Neuraminidase Substitution.
J Virol. 2022;96:e0091822.
- MOYO-GWETE T, Madzivhandila M, Mkhize NN, Kgagudi P, et al
Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus
Variants.
J Virol. 2022 Jul 13:e0055822. doi: 10.1128/jvi.00558.
- FROLOVA EI, Palchevska O, Lukash T, Dominguez F, et al
Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the
Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.
J Virol. 2022 Jul 25:e0075322. doi: 10.1128/jvi.00753.
JAMA
- LARKIN HD
New "Universal" Flu Vaccine Candidate Enters Clinical Trial.
JAMA. 2022;328:518.
- KUEHN BM
More Effective Flu Vaccines Recommended for Older Adults.
JAMA. 2022;328:519.
- KUEHN BM
Reduced HIV Testing and Diagnoses During COVID-19 Pandemic.
JAMA. 2022;328:519.
- CARDOSO CC, Rossi AD, Galliez RM, Faffe DS, et al
Olfactory Dysfunction in Patients With Mild COVID-19 During Gamma, Delta, and
Omicron Waves in Rio de Janeiro, Brazil.
JAMA. 2022 Jun 24. pii: 2793811. doi: 10.1001/jama.2022.11006.
Lancet
- BRIGHTLING CE, Evans RA
Long COVID: which symptoms can be attributed to SARS-CoV-2 infection?
Lancet. 2022;400:411-413.
- VAN DAMME W, Wamai R, Assefa Y, Liesenborghs L, et al
COVID-19 and microbiome diversity in sub-Saharan Africa.
Lancet. 2022;400:429.
- SORENSEN RJD
COVID-19 and microbiome diversity in sub-Saharan Africa - Author's reply.
Lancet. 2022;400:429-430.
- BALLERING AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, et al
Persistence of somatic symptoms after COVID-19 in the Netherlands: an
observational cohort study.
Lancet. 2022;400:452-461.
MMWR Morb Mortal Wkly Rep
- KHUON D, Ogrin S, Engels J, Aldrich A, et al
Notes from the Field: Increase in Pediatric Intracranial Infections During the
COVID-19 Pandemic - Eight Pediatric Hospitals, United States, March 2020-March
2022.
MMWR Morb Mortal Wkly Rep. 2022;71:1000-1001.
- TWENTYMAN E, Wallace M, Roper LE, Anderson TC, et al
Interim Recommendation of the Advisory Committee on Immunization Practices for
Use of the Novavax COVID-19 Vaccine in Persons Aged >/=18 years - United States,
July 2022.
MMWR Morb Mortal Wkly Rep. 2022;71:988-992.
- KOMPANIYETS L, Bull-Otterson L, Boehmer TK, Baca S, et al
Post-COVID-19 Symptoms and Conditions Among Children and Adolescents - United
States, March 1, 2020-January 31, 2022.
MMWR Morb Mortal Wkly Rep. 2022;71:993-999.
N Engl J Med
- LAUNAY O, Cachanado M, Luong Nguyen LB, Ninove L, et al
Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine.
N Engl J Med. 2022 Jun 29. doi: 10.1056/NEJMc2206711.
- TAKASHITA E, Yamayoshi S, Simon V, van Bakel H, et al
Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and
BA.5 Subvariants.
N Engl J Med. 2022;387:468-470.
- MAIER HE, Balmaseda A, Saborio S, Ojeda S, et al
Protection Associated with Previous SARS-CoV-2 Infection in Nicaragua.
N Engl J Med. 2022 Jul 20. doi: 10.1056/NEJMc2203985.
- TAN SHX, Cook AR, Heng D, Ong B, et al
Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of
Age.
N Engl J Med. 2022 Jul 20. doi: 10.1056/NEJMoa2203209.
- KOHANE I, Omenn GS
Understanding Covid Vaccine Efficacy over Time - Bridging a Gap Between Public
Health and Health Care.
N Engl J Med. 2022 Aug 6. doi: 10.1056/NEJMp2201084.
- JOST TS
Considering Race and Ethnicity in Covid Risk Assessments - Legal Concerns and
Possible Solutions.
N Engl J Med. 2022;387:481-483.
- RUBIN EJ, Baden LR, Currier JS, Morrissey S, et al
Audio Interview: Reinventing the Research Infrastructure to Address Covid-19.
N Engl J Med. 2022;387:e13.
- RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Combating Covid-19 Today and Tomorrow.
N Engl J Med. 2022;387:e17.
PLoS Biol
- ROELLE SM, Shukla N, Pham AT, Bruchez AM, et al
Expanded ACE2 dependencies of diverse SARS-like coronavirus receptor binding
domains.
PLoS Biol. 2022;20:e3001738.
- LIU H, Riggi M, Rogers J, Meyer M, et al
A new tool for annotating scientific animations and supporting scientific
dialogue.
PLoS Biol. 2022;20:e3001731.
PLoS Med
- SAARINEN S, Moustgaard H, Remes H, Sallinen R, et al
Income differences in COVID-19 incidence and severity in Finland among people
with foreign and native background: A population-based cohort study of
individuals nested within households.
PLoS Med. 2022;19:e1004038.
PLoS One
- DE REUS YA, Hagedoorn P, Sturkenboom MGG, Grasmeijer F, et al
Tolerability and pharmacokinetic evaluation of inhaled dry powder
hydroxychloroquine in healthy volunteers.
PLoS One. 2022;17:e0272034.
- RIEDEL M, Amann N, Recker F, Hennigs A, et al
The COVID-19 pandemic and its impact on medical teaching in obstetrics and
gynecology-A nationwide expert survey among teaching coordinators at German
university hospitals.
PLoS One. 2022;17:e0269562.
- THORPE A, Fagerlin A, Butler J, Stevens V, et al
Communicating about COVID-19 vaccine development and safety.
PLoS One. 2022;17:e0272426.
- SUN F, Qian P, Cao S, Chen Y, et al
The impact of crop specialization on nutritional intake: Evidence from farm
households in China.
PLoS One. 2022;17:e0272347.
- MATALONI F, Colais P, Pinnarelli L, Fusco D, et al
The impact of the SARS COV-2 pandemic on pediatric accesses in ED: A Healthcare
Emergency Information System analysis.
PLoS One. 2022;17:e0272569.
- AEMRO A, Fentie B, Wassie M
Adherence to Covid-19 mitigation measures and its associated factors among health
care workers at referral hospitals in Amhara regional state of Ethiopia.
PLoS One. 2022;17:e0272570.
- ARNETZ BB, Goetz C, vanSchagen J, Baer W, et al
Patient-reported factors associated with avoidance of in-person care during the
COVID-19 pandemic: Results from a national survey.
PLoS One. 2022;17:e0272609.
- AL-OBAYDI S, Hennrikus E, Mohammad N, Lehman EB, et al
Hesitancy and reactogenicity to mRNA-based COVID-19 vaccines-Early experience
with vaccine rollout in a multi-site healthcare system.
PLoS One. 2022;17:e0272691.
- WILLIAMS CP, Rocque GB, Caston NE, Gallagher KD, et al
Health insurance and financial hardship in cancer survivors during the COVID-19
pandemic.
PLoS One. 2022;17:e0272740.
- NGUYEN N, Lane B, Lee S, Gorman SL, et al
A mixed methods study evaluating acceptability of a daily COVID-19 testing
regimen with a mobile-app connected, at-home, rapid antigen test: Implications
for current and future pandemics.
PLoS One. 2022;17:e0267766.
- AGGARWAL S, Jeong D, Kumar N, Park DS, et al
COVID-19 market disruptions and food security: Evidence from households in rural
Liberia and Malawi.
PLoS One. 2022;17:e0271488.
- OKENDO J, Musanabaganwa C, Mwangi P, Nyaga M, et al
SARS-CoV-2-positive patients display considerable differences in proteome
diversity in urine, nasopharyngeal, gargle solution and bronchoalveolar lavage
fluid samples.
PLoS One. 2022;17:e0271870.
- PONNAIAH M, Ganesan S, Bhatnagar T, Thulasingam M, et al
Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral
mucormycosis regardless of COVID-19 hospitalization: Case-control study, India.
PLoS One. 2022;17:e0272042.
- CASTELLANOS-SERRANO C, Escribano G, Paredes-Gazquez J, San-Martin Gonzalez E, et al
What is behind the gender gap in economics distance education: Age, work-life
balance and COVID-19.
PLoS One. 2022;17:e0272341.
- MCDERMID P, Sooppiyaragath S, Craig A, Sheel M, et al
Psychological and financial impacts of COVID-19-related travel measures: An
international cross-sectional study.
PLoS One. 2022;17:e0271894.
- TAHA M, Elahi M, Wahby K, Samavati L, et al
Incidence and risk factors of COVID-19 associated pneumothorax.
PLoS One. 2022;17:e0271964.
- ALAHYARI S, Rajaeinejad M, Jalaeikhoo H, Chegini L, et al
Immunological evaluation of patients with 2019 novel coronavirus pneumonia: CD4+
and CD16+ cells may predict severity and prognosis.
PLoS One. 2022;17:e0268712.
- KUNNO J, Supawattanabodee B, Sumanasrethakul C, Wiriyasirivaj B, et al
Burnout prevalence and contributing factors among healthcare workers during the
COVID-19 pandemic: A cross-sectional survey study in an urban community in
Thailand.
PLoS One. 2022;17:e0269421.
- KOLTE A, Mahajan Y, Vasa L
Balanced diet and daily calorie consumption: Consumer attitude during the
COVID-19 pandemic from an emerging economy.
PLoS One. 2022;17:e0270843.
- CALVO-PANIAGUA J, Diaz-Arribas MJ, Valera-Calero JA, Gallardo-Vidal MI, et al
A tele-health primary care rehabilitation program improves self-perceived
exertion in COVID-19 survivors experiencing Post-COVID fatigue and dyspnea: A
quasi-experimental study.
PLoS One. 2022;17:e0271802.
- RICHARDSON S, Martinez J, Hirsch JS, Cerise J, et al
Association of race/ethnicity with mortality in patients hospitalized with
COVID-19.
PLoS One. 2022;17:e0267505.
- FACCIN M, Gargiulo F, Atlani-Duault L, Ward JK, et al
Assessing the influence of French vaccine critics during the two first years of
the COVID-19 pandemic.
PLoS One. 2022;17:e0271157.
- SANGVERAPHUNSIRI T, Fukushige T, Jongwiriyanurak N, Tanaksaranond G, et al
Impacts of the COVID-19 pandemic on the spatio-temporal characteristics of a
bicycle-sharing system: A case study of Pun Pun, Bangkok, Thailand.
PLoS One. 2022;17:e0272537.
- HAMMAMI R, Jdidi J, Chakroun O, Issaoui F, et al
Thromboembolic events in COVID-19 ambulatory patients: An observational study
about incidence, and thromboprophylaxis outcomes.
PLoS One. 2022;17:e0270195.
- MARAHWA P, Makota P, Chikomo DT, Chakanyuka T, et al
The psychological impact of COVID-19 on university students in China and Africa.
PLoS One. 2022;17:e0270824.
- AUDEMARD-VERGER A, Le Gouge A, Pestre V, Courjon J, et al
Efficacy and safety of anakinra in adults presenting deteriorating respiratory
symptoms from COVID-19: A randomized controlled trial.
PLoS One. 2022;17:e0269065.
- DENETCLAW WF, Otto ZK, Christie S, Allen E, et al
Dine Navajo Resilience to the COVID-19 pandemic.
PLoS One. 2022;17:e0272089.
- AKTER Y, Barua R, Nasir Uddin M, Muhammad Sanaullah AF, et al
Bioactive potentiality of secondary metabolites from endophytic bacteria against
SARS-COV-2: An in-silico approach.
PLoS One. 2022;17:e0269962.
- SILVERBERG JI, Zyskind I, Naiditch H, Zimmerman J, et al
Predictors of chronic COVID-19 symptoms in a community-based cohort of adults.
PLoS One. 2022;17:e0271310.
- RAO S, Moss A, Lamb M, Innis BL, et al
Vital sign predictors of severe influenza among children in an emergent care
setting.
PLoS One. 2022;17:e0272029.
- HUIBERTS A, van Cleef B, Tjon-A-Tsien A, Dijkstra F, et al
Influenza vaccination of school teachers: A scoping review and an impact
estimation.
PLoS One. 2022;17:e0272332.
- JAMLEH A, Aljohani SM, Alzamil FF, Aljuhayyim SM, et al
Assessment of the educational value of endodontic access cavity preparation
YouTube video as a learning resource for students.
PLoS One. 2022;17:e0272765.
- RAYAMAJHI S, Rafi MA, Tripathi N, Dongol AS, et al
Adverse events following immunization with ChAdOx1 nCoV-19 and BBIBP-CorV
vaccine: A comparative study among healthcare professionals of Nepal.
PLoS One. 2022;17:e0272729.
- FU Y, da Fonseca Rezende E Mello J, Fleming BD, Renn A, et al
A humanized nanobody phage display library yields potent binders of SARS CoV-2
spike.
PLoS One. 2022;17:e0272364.
- ATHAYDE GM, Alencar AP
Forecasting Covid-19 in the United Kingdom: A dynamic SIRD model.
PLoS One. 2022;17:e0271577.
- BRANDSMA J, Chenoweth JG, Gregory MK, Krishnan S, et al
Assessing the use of a micro-sampling device for measuring blood protein levels
in healthy subjects and COVID-19 patients.
PLoS One. 2022;17:e0272572.
- SHAH S, Bhattarai SR, Basnet K, Adhikari YR, et al
Post-COVID syndrome: A prospective study in a tertiary hospital of Nepal.
PLoS One. 2022;17:e0272636.
- GEHANNO JF, Grosjean J, Darmoni SJ, Rollin L, et al
Reliability of citations of medRxiv preprints in articles published on COVID-19
in the world leading medical journals.
PLoS One. 2022;17:e0264661.
- SARJOMAA M, Diep LM, Zhang C, Tveten Y, et al
SARS-CoV-2 antibody persistence after five and twelve months: A cohort study from
South-Eastern Norway.
PLoS One. 2022;17:e0264667.
- ALSAGABY SA, Alharbi NK, Alhumaydhi FA, Alsubaie F, et al
Risk factors of SARS-CoV-2 infection in cancer patients pre- and
post-vaccination.
PLoS One. 2022;17:e0272869.
- NKA AD, Ka'e AC, Bouba Y, Ngoufack Jagni Semengue E, et al
Global burden of SARS-CoV-2 infection, hospitalization and case fatality rate
among COVID-19 vaccinated individuals and its associated factors: A systematic
review and meta-analysis protocol.
PLoS One. 2022;17:e0272839.
- CHENG HY, Fung E, Choi KC, Zou HJ, et al
Early risk of acute myocardial infarction following hospitalization for severe
influenza infection in the middle-aged population of Hong Kong.
PLoS One. 2022;17:e0272661.
- MARSDEN KM, Robertson IK, Porter J
Stressors, manifestations and course of COVID-19 related distress among public
sector nurses and midwives during the COVID-19 pandemic first year in Tasmania,
Australia.
PLoS One. 2022;17:e0271824.
- GEBEYEHU DT, East L, Wark S, Islam MS, et al
Impact of COVID-19 on the food security and identifying the compromised food
security dimension: A systematic review protocol.
PLoS One. 2022;17:e0272859.
- DIETEREN CM, van Hulsen MAJ, Rohde KIM, van Exel J, et al
How should ICU beds be allocated during a crisis? Evidence from the COVID-19
pandemic.
PLoS One. 2022;17:e0270996.
- NGUYEN LH, Anyane-Yeboa A, Klaser K, Merino J, et al
The mental health burden of racial and ethnic minorities during the COVID-19
pandemic.
PLoS One. 2022;17:e0271661.
- MEGHANI A, Agarwal S, Zapf AJ, Edwards JG, et al
Schooling amidst a pandemic in the United States: Parents' perceptions about
reopening schools and anticipated challenges during COVID-19.
PLoS One. 2022;17:e0268427.
- MARK E, Udod G, Skinner J, Jones M, et al
Knowledge, attitudes, and practices [KAP] toward COVID-19: A cross-sectional
study in the New York Metropolitan Area and California Bay Area.
PLoS One. 2022;17:e0271212.
- PARK HJ, Lee SG, Oh JS, Nam M, et al
The effects of indoor temperature and humidity on local transmission of COVID-19
and how it relates to global trends.
PLoS One. 2022;17:e0271760.
- HAGHANI M, Abbasi A, Zwack CC, Shahhoseini Z, et al
Trends of research productivity across author gender and research fields: A
multidisciplinary and multi-country observational study.
PLoS One. 2022;17:e0271998.
Proc Natl Acad Sci U S A
- LI W, Wang Q, Liu Y, Small ML, et al
A spatiotemporal decay model of human mobility when facing large-scale crises.
Proc Natl Acad Sci U S A. 2022;119:e2203042119.
- NOONE DP, Dijkstra DJ, van der Klugt TT, van Veelen PA, et al
PTX3 structure determination using a hybrid cryoelectron microscopy and AlphaFold
approach offers insights into ligand binding and complement activation.
Proc Natl Acad Sci U S A. 2022;119:e2208144119.
- GARCIA-MORO E, Zhang J, Calder LJ, Brown NR, et al
Reversible structural changes in the influenza hemagglutinin precursor at
membrane fusion pH.
Proc Natl Acad Sci U S A. 2022;119:e2208011119.
- YANG Z, Wu D, Lu S, Qiu Y, et al
Plasma metabolome and cytokine profile reveal glycylproline modulating antibody
fading in convalescent COVID-19 patients.
Proc Natl Acad Sci U S A. 2022;119:e2117089119.
- JOSEPH M, Wu Y, Dannebaum R, Rubelt F, et al
Global patterns of antigen receptor repertoire disruption across adaptive immune
compartments in COVID-19.
Proc Natl Acad Sci U S A. 2022;119:e2201541119.
- CARIOU M, Picard L, Gueguen L, Jacquet S, et al
Distinct evolutionary trajectories of SARS-CoV-2-interacting proteins in bats and
primates identify important host determinants of COVID-19.
Proc Natl Acad Sci U S A. 2022;119:e2206610119.
Vaccine
- CHEN H, Huang Z, Chang S, Hu M, et al
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm
BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza
vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A
multicentre, non-inferiorit
Vaccine. 2022 Jul 29. pii: S0264-410X(22)00919.
- SHENYU W, Xiaoqian D, Bo C, Xuan D, et al
Immunogenicity and safety of a SARS-CoV-2 inactivated vaccine (CoronaVac)
co-administered with an inactivated quadrivalent influenza vaccine: A randomized,
open-label, controlled study in healthy adults aged 18 to 59 years in China.
Vaccine. 2022 Jul 26. pii: S0264-410X(22)00908.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016